Volume 42, Issue 6 (May 2017)



Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders

G Sanacora, H Heimer, D Hartman, S J Mathew, M Frye, C Nemeroff and R Robinson Beale

Neuropsychopharmacology 42: 1179-1181; advance online publication, October 12, 2016; doi:10.1038/npp.2016.193


Original Articles

Genetic and Modeling Approaches Reveal Distinct Components of Impulsive Behavior

Katherine M Nautiyal, Melanie M Wall, Shuai Wang, Valerie M Magalong, Susanne E Ahmari, Peter D Balsam, Carlos Blanco and René Hen

Neuropsychopharmacology 42: 1182-1191; advance online publication, January 18, 2017; doi:10.1038/npp.2016.277

Minimum Electric Field Exposure for Seizure Induction with Electroconvulsive Therapy and Magnetic Seizure Therapy

Won H Lee, Sarah H Lisanby, Andrew F Laine and Angel V Peterchev

Neuropsychopharmacology 42: 1192-1200; advance online publication, January 25, 2017; doi:10.1038/npp.2016.276

Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities

Meng Li, Liliana Ramona Demenescu, Lejla Colic, Coraline Danielle Metzger, Hans-Jochen Heinze, Johann Steiner, Oliver Speck, Anna Fejtova, Giacomo Salvadore and Martin Walter

Neuropsychopharmacology 42: 1201-1209; advance online publication, October 19, 2016; doi:10.1038/npp.2016.184

Ketamine Treatment and Global Brain Connectivity in Major Depression

Chadi G Abdallah, Lynnette A Averill, Katherine A Collins, Paul Geha, Jaclyn Schwartz, Christopher Averill, Kaitlin E DeWilde, Edmund Wong, Alan Anticevic, Cheuk Y Tang, Dan V Iosifescu, Dennis S Charney and James W Murrough

Neuropsychopharmacology 42: 1210-1219; advance online publication, October 12, 2016; doi:10.1038/npp.2016.186

Ketamine Corrects Stress-Induced Cognitive Dysfunction through JAK2/STAT3 Signaling in the Orbitofrontal Cortex

Michael S Patton, Daniel J Lodge, David A Morilak and Milena Girotti

Neuropsychopharmacology 42: 1220-1230; advance online publication, November 9, 2016; doi:10.1038/npp.2016.236

GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine

Rong-Jian Liu, Catharine Duman, Taro Kato, Brendan Hare, Dora Lopresto, Eunyoung Bang, Jeffery Burgdorf, Joseph Moskal, Jane Taylor, George Aghajanian and Ronald S Duman

Neuropsychopharmacology 42: 1231-1242; advance online publication, October 19, 2016; doi:10.1038/npp.2016.202

Pharmacological Activators of the NR4A Nuclear Receptors Enhance LTP in a CREB/CBP-Dependent Manner

Morgan S Bridi, Joshua D Hawk, Snehajyoti Chatterjee, Stephen Safe and Ted Abel

Neuropsychopharmacology 42: 1243-1253; advance online publication, December 7, 2016; doi:10.1038/npp.2016.253

Impact of Stress and Glucocorticoids on Schema-Based Learning

Lisa Marieke Kluen, Patricia Nixon, Agorastos Agorastos, Klaus Wiedemann and Lars Schwabe

Neuropsychopharmacology 42: 1254-1261; advance online publication, December 14, 2016; doi:10.1038/npp.2016.256

Stress Induces a Shift Towards Striatum-Dependent Stimulus-Response Learning via the Mineralocorticoid Receptor

Susanne Vogel, Floris Klumpers, Tobias Navarro Schröder, Krista T Oplaat, Harm J Krugers, Melly S Oitzl, Marian Joëls, Christian F Doeller and Guillén Fernández

Neuropsychopharmacology 42: 1262-1271; advance online publication, December 21, 2016; doi:10.1038/npp.2016.262

GABAb Receptor Mediates Opposing Adaptations of GABA Release From Two Types of Prefrontal Interneurons After Observational Fear

Lei Liu, Wataru Ito and Alexei Morozov

Neuropsychopharmacology 42: 1272-1283; advance online publication, January 4, 2017; doi:10.1038/npp.2016.273

Context and Auditory Fear are Differentially Regulated by HDAC3 Activity in the Lateral and Basal Subnuclei of the Amygdala

Janine L Kwapis, Yasaman Alaghband, Alberto J López, André O White, Rianne R Campbell, Richard T Dang, Diane Rhee, Ashley V Tran, Allison E Carl, Dina P Matheos and Marcelo A Wood

Neuropsychopharmacology 42: 1284-1294; advance online publication, January 4, 2017; doi:10.1038/npp.2016.274

Sex Differences in μ-Opioid Receptor Regulation of the Rat Locus Coeruleus and Their Cognitive Consequences Open

Herminio M Guajardo, Kevin Snyder, Andrew Ho and Rita J Valentino

Neuropsychopharmacology 42: 1295-1304; advance online publication, December 14, 2016; doi:10.1038/npp.2016.252

Trace Amine-Associated Receptor 1 Regulates Wakefulness and EEG Spectral Composition

Michael D Schwartz, Sarah W Black, Simon P Fisher, Jeremiah B Palmerston, Stephen R Morairty, Marius C Hoener and Thomas S Kilduff

Neuropsychopharmacology 42: 1305-1314; advance online publication, October 26, 2016; doi:10.1038/npp.2016.216

Chemogenetic Activation of Midbrain Dopamine Neurons Affects Attention, but not Impulsivity, in the Five-Choice Serial Reaction Time Task in Rats

Linde Boekhoudt, Elisa S Voets, Jacques P Flores-Dourojeanni, Mieneke CM Luijendijk, Louk JMJ Vanderschuren and Roger AH Adan

Neuropsychopharmacology 42: 1315-1325; advance online publication, November 16, 2016; doi:10.1038/npp.2016.235

Methylphenidate Enhances Early-Stage Sensory Processing and Rodent Performance of a Visual Signal Detection Task

Rachel L Navarra, Brian D Clark, Andrew T Gargiulo and Barry D Waterhouse

Neuropsychopharmacology 42: 1326-1337; advance online publication, January 4, 2017; doi:10.1038/npp.2016.267

Neurophysiological Characterization of Attentional Performance Dysfunction in Schizophrenia Patients in a Reverse-Translated Task

Jared W Young, Andrew W Bismark, Yinming Sun, Wendy Zhang, Meghan McIlwain, Ibrahim Grootendorst and Gregory A Light

Neuropsychopharmacology 42: 1338-1348; advance online publication, February 8, 2017; doi:10.1038/npp.2016.268

Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes

Emilie I Petit, Zuzanna Michalak, Rachel Cox, Colm M P O’Tuathaigh, Niamh Clarke, Orna Tighe, Konrad Talbot, Derek Blake, Josephine Joel, Alexander Shaw, Steven A Sheardown, Alastair D Morrison, Stephen Wilson, Ellen M Shapland, David C Henshall, James N Kew, Brian P Kirby and John L Waddington

Neuropsychopharmacology 42: 1349-1360; advance online publication, January 25, 2017; doi:10.1038/npp.2016.282

Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk Study Open

New Fei Ho, Daphne J Holt, Mike Cheung, Juan Eugenio Iglesias, Alex Goh, Mingyuan Wang, Joseph KW Lim, Joshua de Souza, Joann S Poh, Yuen Mei See, Alison R Adcock, Stephen J Wood, Michael WL Chee, Jimmy Lee and Juan Zhou

Neuropsychopharmacology 42: 1361-1370; advance online publication, February 1, 2017; doi:10.1038/npp.2017.5

Extra navigation